4th Quarter - Report

CAPITOL COUNSEL LLC for GENENTECH

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, including related provisions modifying Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements in H.R. 3, the Lower Drug Costs Now Act and S. 2543, the Prescription Drug Pricing Reduction Act; use of step therapy in Medicare and health insurance coverage; and legislative efforts to modify the Center for Medicare & Medicaid Innovation to preserve patient access to medically-necessary treatments.

Foreign entity interest: Foreign parent affected by policies affecting U.S. subsidiary.

LobbyistCovered position, as disclosed
CAITLIN CANTER —
AARON COHEN —
SHANNON FINLEY —
SARA FRANKO —
MARTIN B. GOLD —
LUKE HATZIS —
DENISE HENRY MORRISEY —
ANN JABLON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3 (116th), S. 2543 (116th)

Health Issues HCR

340B issues and patient access to pharmaceuticals.

Foreign entity interest: Foreign parent affected by policies affecting U.S. subsidiary.

LobbyistCovered position, as disclosed
CAITLIN CANTER —
AARON COHEN —
SHANNON FINLEY —
SARA FRANKO —
MARTIN B. GOLD —
LUKE HATZIS —
DENISE HENRY MORRISEY —
ANN JABLON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.